Moreover, the 36-month beta value for VIGL is 1.79. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 1 as “sell.”
The public float for VIGL is 18.72M and currently, short sellers hold a 2.60% of that float. On November 27, 2024, VIGL’s average trading volume was 87.57K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
VIGL) stock’s latest price update
The stock of Vigil Neuroscience Inc (NASDAQ: VIGL) has decreased by -26.91 when compared to last closing price of 3.01. Despite this, the company has experienced a -27.63% fall in its stock price over the last five trading sessions. prnewswire.com reported 2024-10-09 that NEW YORK, Oct. 9, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Vigil Neuroscience, Inc. (NASDAQ: VIGL) on behalf of the company’s shareholders. The investigation seeks to determine whether Vigil Neuroscience’s directors breached their fiduciary duties in connection with recent corporate actions.
VIGL’s Market Performance
VIGL’s stock has fallen by -27.63% in the past week, with a monthly drop of -43.59% and a quarterly drop of -37.32%. The volatility ratio for the week is 14.19% while the volatility levels for the last 30 days are 8.22% for Vigil Neuroscience Inc The simple moving average for the last 20 days is -34.93% for VIGL stock, with a simple moving average of -36.86% for the last 200 days.
Analysts’ Opinion of VIGL
Many brokerage firms have already submitted their reports for VIGL stocks, with Morgan Stanley repeating the rating for VIGL by listing it as a “Underweight.” The predicted price for VIGL in the upcoming period, according to Morgan Stanley is $4 based on the research report published on December 19, 2023 of the previous year 2023.
JMP Securities, on the other hand, stated in their research note that they expect to see VIGL reach a price target of $23. The rating they have provided for VIGL stocks is “Mkt Outperform” according to the report published on October 18th, 2023.
Mizuho gave a rating of “Buy” to VIGL, setting the target price at $15 in the report published on March 31st of the previous year.
VIGL Trading at -36.47% from the 50-Day Moving Average
After a stumble in the market that brought VIGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.70% of loss for the given period.
Volatility was left at 8.22%, however, over the last 30 days, the volatility rate increased by 14.19%, as shares sank -42.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -37.14% lower at present.
During the last 5 trading sessions, VIGL fell by -27.63%, which changed the moving average for the period of 200-days by -34.52% in comparison to the 20-day moving average, which settled at $3.38. In addition, Vigil Neuroscience Inc saw -34.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VIGL starting from Verni Christopher, who proposed sale 40,000 shares at the price of $3.62 back on Sep 19 ’24. After this action, Verni Christopher now owns shares of Vigil Neuroscience Inc, valued at $145,000 using the latest closing price.
Stock Fundamentals for VIGL
Current profitability levels for the company are sitting at:
- -45.72 for the present operating margin
- 0.82 for the gross margin
The net margin for Vigil Neuroscience Inc stands at -42.71. The total capital return value is set at -0.88. Equity return is now at value -73.62, with -56.88 for asset returns.
Currently, EBITDA for the company is -88.47 million with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of 30.1. The receivables turnover for the company is 4.9for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.72.
Conclusion
To wrap up, the performance of Vigil Neuroscience Inc (VIGL) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
